Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Evaluate Long-Term Safety, Tolerability, & Efficacy of BMN 111 in Children With Achondroplasia (ACH) (ACH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02724228
Recruitment Status : Active, not recruiting
First Posted : March 31, 2016
Last Update Posted : June 18, 2021
Sponsor:
Information provided by (Responsible Party):
BioMarin Pharmaceutical

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : October 2022
Estimated Study Completion Date : October 2022